NGL Fine Chem Ltd (NGLFINE) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by NGL Fine Chem Ltd on NSE and BSE, with an AI summary of each filing.
NGL FINE-CHEM LIMITED has informed the Exchange about Board Meeting to be held on 06-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2026 .
Intimation · 06 Nov 2026, 5:30 am
To consider and approve the financial results for the period ended September 30, 2026
Intimation · 06 Nov 2026, 5:30 am
NGL Fine Chem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2026 ,inter alia, to consider and approve 1. To consider and approve the ....
Intimation · 06 Nov 2026, 5:30 am
NGL Fine-Chem Schedules Board Meeting on 6th Nov'26 to Consider Q2 Results NGL Fine-Chem Limited has scheduled a Board of Directors meeting on 6th Nov'26 to consider and approve the unaudited standalone and consolidated financial results for the quarter and half-year ended 30th Sep'26. In accordance with SEBI insider trading regulations, the trading window for dealing in company securities has been closed since 1st Oct'26 and will reopen 48 hours after the declaration of the financial results.
Intimation of receipt of SEBI Exemption order.
Others (Uncategorized) · 13 Oct 2026, 4:20 pm
SEBI Grants Takeover Exemption for NGL Fine-Chem Promoter Share Transfer to Family Trusts SEBI granted an open-offer exemption under SAST Regulations to Ajita Nachane Family Trust and Rahul Nachane Family Trust for acquiring a combined 29.09% stake (17,96,899 shares) in NGL Fine-Chem Ltd from promoters Ajita Nachane (11.55%) and Rahul Nachane (17.54%) for internal family succession planning. The transaction entails an intra-promoter transfer with no change in overall promoter holding (72.49%), public shareholding (27.51%), or company control. The exemption remains valid for one year from 9th Oct'26, requiring completion and regulatory reporting within 21 days post-acquisition.
Disclosure of Show Cause Notice received from the GST Department
Others (Uncategorized) · 25 Sept 2026, 10:52 pm
NGL Fine-Chem Receives ₹6.19 Crore GST Show Cause Notice NGL Fine-Chem received a Show Cause Notice dated 22nd Sep'26 from the Maharashtra GST Department proposing a total demand of ₹6,18,61,905 for FY 2022-23. The demand comprises tax of ₹3,04,36,444, interest of ₹2,66,42,312, and a penalty of ₹47,83,149, primarily alleging outward tax short-payment of ₹18.31 lakh and excess/ineligible input tax credit availment of ₹2.86 crore. The personal hearing is scheduled for 22nd Oct'26. The company plans to file a detailed reply and expects no material financial or operational impact.
Intimation Under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 - Commencement of Commercial Production of Phase II of Greenfield Facility at Tarapur.
Others (Uncategorized) · 24 Sept 2026, 8:57 pm
NGL Fine-Chem Fully Operationalises Tarapur Greenfield Facility with Phase II Commercial Production NGL Fine-Chem has commenced commercial production for Phase II of its Greenfield facility at Tarapur, Maharashtra, effective 24th Sep'26, marking the site's full commissioning following Phase I operationalisation on 11th Mar'25. The facility adds flexible manufacturing infrastructure across the company's active pharmaceutical ingredient (API) portfolio. Total capital expenditure incurred stands at approximately ₹222 crore, financed through ₹138 crore in internal accruals and ₹84 crore via bank term loans. Actual production capacity will vary based on product mix, manufacturing schedules, and specific API requirements.
This has reference to our earlier intimation dated September 10, 2026, made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, with ....
Others · 16 Sept 2026, 8:37 pm
NGL Fine-Chem Concludes Virtual One-on-One Analyst and Investor Meeting NGL Fine-Chem Limited conducted a virtual one-on-one meeting with analysts and investors on 16th Sep'26, following its earlier intimation on 10th Sep'26. The company confirmed that no formal presentation was delivered during the session. Discussions were strictly limited to information already accessible in the public domain, and no Unpublished Price Sensitive Information (UPSI) was disclosed to participants.
This is to inform you that a One to One meet has been scheduled on Wednesday, September 16, 2026 with Analyst/Investor.
Intimation · 10 Sept 2026, 11:21 pm
NGL Fine-Chem Schedules Virtual Investor Meeting on 16th Sep'26 NGL Fine-Chem Limited announced a virtual one-on-one meeting with an analyst/investor scheduled for 16th Sep'26 at 11:30 AM IST, pursuant to Regulation 30 of SEBI Listing Regulations. The company confirmed that no unpublished price-sensitive information will be shared during the interaction.
Submission of Voting Results and Scrutinizer''s Report for the 45th Annual General Meeting of the Compny
Annual General Meeting · 27 Aug 2026, 11:22 pm
Summary of Proceedings of the 45th Annual General Meeting of NGL Fine-Chem Limited
Annual General Meeting · 26 Aug 2026, 3:17 am
Corrigendum to the 45th Annual Report for the Financial Year 2025-26
Annual Report · 20 Aug 2026, 8:36 pm
Investors Presentation - Q1FY27
Investor Presentation · 17 Aug 2026, 8:22 pm
NGL Fine-Chem Q1FY27: Strong YoY Growth Driven by Margin Expansion and Forex Gains NGL Fine-Chem reported a strong Q1FY27 with PAT at ₹18.40 crore (+99.1% YoY) and EBITDA at ₹23.29 crore (+112.2% YoY). Revenue grew 33.6% YoY to ₹139.16 crore, although it declined 6.8% QoQ. EBITDA margin expanded significantly to 16.73%, a 620 bps YoY improvement. Profitability was boosted by inventory gains and a ₹2.5 crore forex gain, reversing a Q4FY26 loss. Management expects margins to moderate. The Phase II capex is on schedule for commissioning in the current quarter, supporting future growth.
Board comments on fines levied by the Exchanges
Others (Uncategorized) · 13 Aug 2026, 1:26 am
NGL Fine-Chem Fined by Exchanges for SEBI Compliance Delay NGL Fine-Chem was fined Rs. 11,800 each by the BSE and NSE for delaying the intimation of a Board Meeting, a violation of SEBI Listing Regulations 29(2)/29(3). The non-compliance occurred in May'26. In its board meeting on Aug 12, 2026, the company stated the delay was inadvertent and due to a procedural lapse. The Board has paid the fines and noted it has strengthened internal compliance monitoring to prevent future occurrences, advising management to ensure strict adherence to prescribed timelines.
Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2026.
Financial Result · 13 Aug 2026, 12:32 am
NGL Fine-Chem Q1FY27: Strong YoY Profit Growth Amid Revenue Decline NGL Fine-Chem reported robust YoY growth for Q1FY27 ending Jun 30, '26. Consolidated net profit rose 98.3% YoY to ₹184.0M, with revenue declining 6.8% YoY to ₹1,391.6M. Sequentially, revenue fell 6.7% and PAT grew 36.4%. The standalone business showed similar trends, with PAT up 115.2% YoY to ₹164.5M on a 6.9% YoY revenue drop to ₹1,367.1M. Improved margins were a key driver, as PAT margin expanded to 13.2% (consolidated) and 12.0% (standalone) from 6.3% and 7.1% YoY, respectively.
We wish to inform you that, the Board of Directors of the Company at their meeting held today i.e. on Wednesday, August 12, 2026 has inter-alia considered and approved the following: 1. ....
Outcome · 13 Aug 2026, 12:13 am
NGL Fine Chem Ltd - Financial Result for the Quarter ended 30th Jun'26 (Consolidated, INR Lakh) ■ Revenue: 13,916 (+33.6% YoY | -6.7% QoQ) ■ EBITDA: 2,329 (+112.2% YoY | +8.8% QoQ) ■ EBITDA Margin (%): 16.7 (+620 bps YoY | +239 bps QoQ) ■ PAT: 1,840 (+99.1% YoY | +36.4% QoQ) ■ EPS (INR): 29.8 (+99.1% YoY | +36.4% QoQ)
NGL Fine Chem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve the Unaudited Standalone & Consolidated ....
Intimation · 12 Aug 2026, 5:30 am
NGL Fine-Chem Board Meeting Scheduled to Approve Q1FY27 Results NGL Fine-Chem has scheduled a Board of Directors meeting for Aug 12, '26, to consider and approve its unaudited standalone and consolidated financial results for the quarter ended Jun 30, '26. The trading window for insiders was closed from Jul 1, '26, and will reopen on Aug 15, '26, 48 hours after the results are declared. This announcement precedes the company's official Q1FY27 earnings release.
Submission of Business Responsibility and Sustainability Reporting for FY 2025-26
Others (Uncategorized) · 31 Jul 2026, 11:57 pm
NGL Fine-Chem Submits Business Responsibility and Sustainability Report for FY26 NGL Fine-Chem submitted its Business Responsibility and Sustainability Report for FY26 on 31 Jul'26. Pharmaceutical manufacturing accounts for 100% of turnover, with exports contributing over 75%. In FY26, the company had 463 employees and a turnover rate for permanent employees of 127, up from 89 in FY25. Spending on wellbeing measures doubled to 0.30% of revenue from 0.14% in FY25. Accounts payable days improved significantly to 35 from 107. The company reported zero complaints across community, investor, customer, and employee categories.
Submission of Annual Report as per Reg. 34 (1)
Others (Uncategorized) · 31 Jul 2026, 11:53 pm
Submission of Notice of 45 Annual General Meeting and Annual Report of the Company for the Financial Year 2025-26
Annual General Meeting · 31 Jul 2026, 11:44 pm
Transcript of the Earnings Call - Q4 & FY 26
Transcript · 31 May 2026, 4:19 am
Audio Recording of Earning Conference Call Q4 & FY26
Audio / Video · 25 May 2026, 11:08 pm
NGL Fine-Chem Publishes Q4 & FY26 Earnings Call Audio Recording NGL Fine-Chem has released the audio recording for its Q4 & FY26 earnings conference call. The call, held on 25 May'26, discussed the company's operational and financial performance with investors and analysts. The recording is now accessible on the company's official website. This follows the company's regulatory disclosure obligations under SEBI regulations.
Investors Presentation Q4 & FY26
Investor Presentation · 23 May 2026, 4:15 am
NGL Fine-Chem Q4 & FY26 Results: Strong Volume-Led Growth with Margin Pressure NGL Fine-Chem reported robust Q4 FY26 results driven by volume expansion. Revenue grew 57.1% YoY to ₹149.2 Cr, while full-year revenue rose 36.0% YoY to ₹501.0 Cr. Q4 EBITDA margin was 14.35%, down 315 bps QoQ due to higher input costs but up 769 bps YoY. FY26 PAT surged 127.8% YoY to ₹48.1 Cr. The animal API segment dominated revenue at 95%. Phase II capex commissioning is delayed to early Q2 FY27, with commercial production on track for H2 FY27. Management noted partial price pass-throughs should aid future margins.
The Record Date for the purpose of Annual General meeting and payment of final dividend is Tuesday, August 18, 2026
Dividend · 22 May 2026, 3:14 am
NGL Fine-Chem Board Declares Final Dividend and Approves FY26 Results The Board approved FY26 financial results and recommended a final dividend of Rs. 1.75 per share (face value Rs. 5). The record date for the dividend payment is set for 18 Aug'26. For Q4 FY26, consolidated revenue was Rs. 15,169.20 lakhs and Profit After Tax stood at Rs. 1,348.56 lakhs. Full-year FY26 consolidated PAT reached Rs. 4,812.67 lakhs. The 45th AGM will be held on 25 Aug'26. The Board also approved the re-appointment of Mr. Rajesh Lawande as Whole-Time Director for five years.
Outcome of Board Meeting
Change in Management · 22 May 2026, 3:09 am
NGL Fine-Chem Board Declares Dividend and Approves FY26 Results NGL Fine-Chem’s board approved its Q4 and FY26 results on 21 May'26 and recommended a final dividend of Rs. 1.75 per share. For FY26, consolidated revenue from operations grew 36% YoY to Rs. 50,095.47 lakhs, while Profit After Tax rose 128% YoY to Rs. 4,812.67 lakhs. Q4FY26 consolidated PAT was Rs. 1,348.56 lakhs vs. Rs. 54.36 lakhs in Q4FY25. The 45th AGM is scheduled for 25 Aug'26, with a dividend record date of 18 Aug'26. The board also approved key reappointments.
Outcome of Board Meeting Dated May 21, 2026
Dividend · 22 May 2026, 2:58 am
NGL Fine-Chem Recommends Rs 1.75/Share Dividend For FY26 The Board approved FY26 financial results and recommended a final dividend of Rs 1.75 per equity share (face value Rs 5). The record date is set for 18 Aug'26, and the 45th AGM will be held on 25 Aug'26. For the year ended 31 Mar'26, consolidated revenue from operations grew 36% YoY to Rs 50,095.47 lakhs, while net profit rose 128.8% YoY to Rs 4,812.67 lakhs. The board also approved the re-appointment of Mr. Rajesh Lawande as Whole-Time Director for five years from 01 Jun'26.